← FDA Drug Approvals (Drugs@FDA)

TARCEVA

NDA · New Drug Application · Sponsor: OSI PHARMS · Approved 2004-11-18

Drug application

FDA Application #

NDA021743

Application type

New Drug Application

Brand name

TARCEVA

Generic name

Erlotinib Hydrochloride

Active ingredients

ERLOTINIB HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

OSI PHARMS

First approval

2004-11-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown